Antitrust 2018: Trends and Developments to Watch
Cooley M&A
JANUARY 24, 2018
Trump’s agency appointments are setting the antitrust agenda in 2018. We offer insights on what to expect in the new year, including an increased scrutiny on vertical mergers; a heightened focus on structural remedies in enforcement actions; a continued spotlight on the pharmaceutical industry – particularly with respect to proposed mergers and reverse payment agreements; a potential Supreme Court ruling on the rule of reason; criminal prosecutions of no-poach and wage-fixing agreements; increas
Let's personalize your content